Skip to main content Skip to footer
Nighthawk Biosciences, Inc.
  • Home
  • About
    • Management Team
    • Board of Directors
  • Scorpius Biomanufacturing
  • Investors & News
    • Overview
    • News & Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Management Team
      • Presentations
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • Overview
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Corporate Presentation
  • Contact

Press Releases

Investors & News

Investors & News

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Corporate Presentation
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jun 28, 2017 7:00am EDT

Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives First Tranche of $15.2 Million CPRIT Grant Award

Jun 12, 2017 7:30am EDT

Heat Biologics to Present at the 2017 BIO International Convention

Jun 07, 2017 7:00am EDT

Heat Biologics to Present at the 2017 Marcum Microcap Conference

Jun 05, 2017 7:59am EDT

Heat Biologics Presents Poster on its Phase 2 Trial Evaluating HS-410 at ASCO Annual Meeting

May 30, 2017 11:15am EDT

Heat Biologics to Present Poster at 2017 ASCO Annual Meeting

May 11, 2017 7:15am EDT

Heat Biologics Provides Business and Clinical Update for the First Quarter of 2017

May 01, 2017 10:00am EDT

Heat Biologics Announces Completion of Acquisition of Pelican Therapeutics

Apr 26, 2017 7:00am EDT

Heat Biologics to Present at PIONEERS 2017 Presented by Joseph Gunnar & Co.

Apr 05, 2017 8:00am EDT

Heat Biologics Presents New Preclinical Data from OncoSec Collaboration at the American Association for Cancer Research (AACR) Annual Meeting

Mar 31, 2017 7:00am EDT

Heat Biologics Reports Fiscal Year 2016 Financial Results

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • …
  • Page 31
  • Next Pagearrow_forward
rss_feed News RSS
NightHawk Biosciences
  • Email Alerts
  • Contacts
  • RSS News Feed
©2024 Nighthawk Biosciences, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap
  • Visit us on LinkedIn
  • Visit us on Twitter
  • Visit us on YouTube
  • Visit us on Facebook

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.